USMLE® Step 2 CK · Psychiatry · Topic PSY-MOOD-02
Antidepressant selection, SSRI/SNRI pharmacology & discontinuation
Antidepressant selection, SSRI/SNRI pharmacology & discontinuation (PSY-MOOD-02) in USMLE® Step 2 CK Psychiatry (USMLE® Step 2 CK Review Book p. 619). Guideline basis: NICE NG222 (2022/current), CG113 + CG185 (updated 2025); VA/DoD MDD (2022) + PTSD (2023 official clinical summary).. Covers: First-line agent selection, Adverse effects and monitoring, Discontinuation syndrome, Serotonin syndrome and dangerous interactions. Practice 34 QuestionBank questions, ChartWalk bedside clinical algorithms, FlashCards, and ImageBank on TheCodexes.com. Understand beyond your boards.
- Topic Code
- PSY-MOOD-02
- Chapter
- Psychiatry
- Review Book Page
- p. 619
- QuestionBank Items
- 34 questions
Primary Guideline / Source: NICE NG222 (2022/current), CG113 + CG185 (updated 2025); VA/DoD MDD (2022) + PTSD (2023 official clinical summary).
Key Clinical Sections
- First-line agent selection
- Adverse effects and monitoring
- Discontinuation syndrome
- Serotonin syndrome and dangerous interactions
- Generalized anxiety disorder (GAD) and PTSD pharmacotherapy